Recall: D-0396-2025

Class II - Potentially Harmful

Class IIClassification

2025-04-10Initiated

OngoingStatus

ACCORD HEALTHCARE, INC.Firm

Product

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-450-17

Reason

Subpotent

Distribution

Nationwide US.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.